Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
Related Experiment Video
Updated: Jul 30, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Shuichiro Shiina1, Hitoshi Maruyama2, Maki Tobari2
1Department of Gastroenterology, Juntendo University, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan. s.shiina@gmail.com.
No abstract available in PubMed .
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:25Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Related Concept Videos
Tumor Immunotherapy
Obesity
Psychoneuroimmunology: Diabetes and Cancer
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis II: Collaborative Care
Assessment: